Loading...

Cheryl Ewing, MD

Title(s)Professor, Surgery
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-353-7070
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Cheryl Ewing is Associate Professor of Surgery at UCSF Mount Zion Hospital. Her focus is in breast cancer surgery and sentinel lymph node dissection. Her other interests include quality of care and evaluation of barriers to medical and breast care for minority women.

    Dr. Ewing completed her undergraduate education at the University of Michigan, and received her medical degree from Wayne State University School of Medicine. She then went on to complete her residency at University of Michigan Medical School, and then her fellowship at the University of Chicago. She joined the faculty at UCSF in 2001.

    Dr. Ewing has lectured extensively at many local, national, and international events. She has been very active in mentoring residents and fellows, serving four years as the Mount Zion Site Director for the Surgery 110 Rotations and teaching several CME courses and Grand Rounds.

    Dr. Ewing is involved in several studies involving quality of care among breast cancer survivors. Specifically, these involve post-surgery symptom management, and customizing risk assessment and tailoring treatment to the individual patient's medical profile and preferences. Her primary focus in on how being a breast cancer survivor affects the quality of life in different race/ethnic groups, and how that relationship is modified by social support, depression, and spirituality.

    Dr. Ewing is a member of most of the major surgical societies, and has been the recipient of several awards, including the Susan G. Komen Local Hero Award.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience. Ann Surg Oncol. 2020 Oct 06. Son JD, Piper M, Hewitt K, Alvarado M, Esserman LJ, Ewing C, Wong JM, Mukhtar RA. PMID: 33025355.
      View in: PubMed   Mentions:    Fields:    
    2. Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2020 Oct; 183(3):661-667. Abel MK, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Park C, Mukhtar RA. PMID: 32696313.
      View in: PubMed   Mentions:    Fields:    
    3. Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater. Am J Surg. 2020 Jun 19. Abel MK, Brabham CE, Guo R, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Mukhtar RA. PMID: 32622509.
      View in: PubMed   Mentions:    Fields:    
    4. Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival. Breast Cancer Res Treat. 2020 May; 181(1):23-29. Mukhtar RA, Krings G, Chen YY, Mamounas ME, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Rugo H. PMID: 32240457.
      View in: PubMed   Mentions:    Fields:    
    5. Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast. NPJ Breast Cancer. 2019; 5:29. Piper ML, Wong J, Fahrner-Scott K, Ewing C, Alvarado M, Esserman LJ, Mukhtar RA. PMID: 31508489.
      View in: PubMed   Mentions:
    6. Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer. Clin Cancer Res. 2019 09 01; 25(17):5388-5397. Magbanua MJM, Yau C, Wolf DM, Lee JS, Chattopadhyay A, Scott JH, Bowlby-Yoder E, Hwang ES, Alvarado M, Ewing CA, Delson AL, Van't Veer LJ, Esserman L, Park JW. PMID: 31142502.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2019; 5:2. Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Goodellas C, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ. PMID: 30675512.
      View in: PubMed   Mentions:
    8. Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2018; 4:26. Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ. PMID: 30131975.
      View in: PubMed   Mentions:
    9. Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients. Ann Surg Oncol. 2018 Oct; 25(11):3165-3170. Mukhtar RA, Wong J, Piper M, Zhu Z, Fahrner-Scott K, Mamounas M, Sbitany H, Alvarado M, Foster R, Ewing C, Esserman L. PMID: 30054826.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Complications After Total Skin-Sparing Mastectomy and Expander-Implant Reconstruction: Effects of Radiation Therapy on the Stages of Reconstruction. Ann Plast Surg. 2018 Jan; 80(1):10-13. Peled AW, Sears M, Wang F, Foster RD, Alvarado M, Wong J, Ewing CA, Sbitany H, Esserman LJ, Fowble B. PMID: 28671888.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women. Clin Breast Cancer. 2018 02; 18(1):e107-e113. Fowble B, Jairam AK, Wang F, Peled A, Alvarado M, Ewing C, Esserman L, Park C, Lazar A. PMID: 28830795.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer. N Engl J Med. 2016 Jul 07; 375(1):23-34. Rugo HS, Olopade OI, DeMichele A, Yau C, van 't Veer LJ, Buxton MB, Hogarth M, Hylton NM, Paoloni M, Perlmutter J, Symmans WF, Yee D, Chien AJ, Wallace AM, Kaplan HG, Boughey JC, Haddad TC, Albain KS, Liu MC, Isaacs C, Khan QJ, Lang JE, Viscusi RK, Pusztai L, Moulder SL, Chui SY, Kemmer KA, Elias AD, Edmiston KK, Euhus DM, Haley BB, Nanda R, Northfelt DW, Tripathy D, Wood WC, Ewing C, Schwab R, Lyandres J, Davis SE, Hirst GL, Sanil A, Berry DA, Esserman LJ. PMID: 27406347.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCTClinical Trials
    13. The Impact of Radiation Therapy, Lymph Node Dissection, and Hormonal Therapy on Outcomes of Tissue Expander-Implant Exchange in Prosthetic Breast Reconstruction. Plast Reconstr Surg. 2016 Jan; 137(1):1-9. Wang F, Peled AW, Chin R, Fowble B, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H. PMID: 26368331.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    14. Tissue Expander Reconstruction After Total Skin-Sparing Mastectomy: Defining the Effects of Coverage Technique on Nipple/Areola Preservation. Ann Plast Surg. 2016 Jan; 77(1):17-24. Sbitany H, Wang F, Peled AW, Alvarado M, Ewing CA, Esserman LJ, Foster RD. PMID: 25057918.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    15. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome. Ann Surg Oncol. 2016 Mar; 23(3):715-21. Johnson J, Esserman L, Ewing C, Alvarado M, Park C, Fowble B. PMID: 26714943.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    16. Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer. Ann Surg Oncol. 2015 Oct; 22(10):3338-45. Wang F, Amara D, Peled AW, Sbitany H, Foster RD, Ewing CA, Alvarado M, Esserman LJ. PMID: 26215194.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    17. Expanding the Indications for Total Skin-Sparing Mastectomy: Is It Safe for Patients with Locally Advanced Disease? Ann Surg Oncol. 2016 Jan; 23(1):87-91. Peled AW, Wang F, Foster RD, Alvarado M, Ewing CA, Sbitany H, Esserman LJ. PMID: 26170194.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    18. Tumor Involvement of the Nipple in Total Skin-Sparing Mastectomy: Strategies for Management. Ann Surg Oncol. 2015 Nov; 22(12):3803-8. Amara D, Peled AW, Wang F, Ewing CA, Alvarado M, Esserman LJ. PMID: 26023040.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    19. Rates of Reconstruction Failure in Patients Undergoing Immediate Reconstruction With Tissue Expanders and/or Implants and Postmastectomy Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Jul 01; 92(3):634-41. Fowble B, Park C, Wang F, Peled A, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H, Hanlon A. PMID: 25936815.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    20. The impact of breast mass on outcomes of total skin-sparing mastectomy and immediate tissue expander-based breast reconstruction. Plast Reconstr Surg. 2015 Mar; 135(3):672-9. Wang F, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H. PMID: 25719689.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    21. Immediate implant-based breast reconstruction following total skin-sparing mastectomy: defining the risk of preoperative and postoperative radiation therapy for surgical outcomes. Plast Reconstr Surg. 2014 Sep; 134(3):396-404. Sbitany H, Wang F, Peled AW, Lentz R, Alvarado M, Ewing CA, Esserman LJ, Fowble B, Foster RD. PMID: 25158699.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    22. Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes. Ann Surg Oncol. 2014 Oct; 21(10):3223-30. Wang F, Peled AW, Garwood E, Fiscalini AS, Sbitany H, Foster RD, Alvarado M, Ewing C, Hwang ES, Esserman LJ. PMID: 25052246.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    23. Immediate implant-based breast reconstruction following total skin-sparing mastectomy in women with a history of augmentation mammaplasty: assessing the safety profile. Plast Reconstr Surg. 2014 Jul; 134(1):1-9. Sbitany H, Wang F, Saeed L, Alvarado M, Ewing CA, Esserman LJ, Foster RD. PMID: 24622575.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol. 2014 Sep; 21(9):2889-96. Cureton EL, Yau C, Alvarado MD, Krontiras H, Ollila DW, Ewing CA, Monnier S, Esserman LJ. PMID: 24788555.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    25. Abstract 124: outcomes of total skin-sparing mastectomy and reconstruction in 924 breasts over 11 years. Plast Reconstr Surg. 2014 Mar; 133(3 Suppl):139. Wang F, Peled A, Foster R, Wang E, Ewing C, Alvarado M, Esserman L, Sbitany H. PMID: 25942235.
      View in: PubMed   Mentions:    Fields:    
    26. Total skin-sparing mastectomy in BRCA mutation carriers. Ann Surg Oncol. 2014 Jan; 21(1):37-41. Peled AW, Irwin CS, Hwang ES, Ewing CA, Alvarado M, Esserman LJ. PMID: 23982256.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    27. The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study. Plast Reconstr Surg. 2012 Jun; 129(6):901e-908e. Peled AW, Foster RD, Garwood ER, Moore DH, Ewing CA, Alvarado M, Hwang ES, Esserman LJ. PMID: 22634688.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    28. Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. Ann Surg. 2012 Jun; 255(6):1151-7. Chang EI, Peled AW, Foster RD, Lin C, Zeidler KR, Ewing CA, Alvarado M, Hwang ES, Esserman LJ. PMID: 22470069.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol. 2012 Oct; 19(11):3402-9. Warren Peled A, Foster RD, Stover AC, Itakura K, Ewing CA, Alvarado M, Hwang ES, Esserman LJ. PMID: 22526909.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    30. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. Clin Breast Cancer. 2011 Mar; 11(1):33-8. Itakura K, Lessing J, Sakata T, Heinzerling A, Vriens E, Wisner D, Alvarado M, Esserman L, Ewing C, Hylton N, Hwang ES. PMID: 21421520.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    31. Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience. Cancer. 2011 Jan 15; 117(2):250-8. Liu LC, Lang JE, Lu Y, Roe D, Hwang SE, Ewing CA, Esserman LJ, Morita E, Treseler P, Leong SP. PMID: 20818649.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    32. Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg. 2010 Sep; 145(9):880-5. Warren Peled A, Itakura K, Foster RD, Hamolsky D, Tanaka J, Ewing C, Alvarado M, Esserman LJ, Hwang ES. PMID: 20855759.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    33. Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? Int J Radiat Oncol Biol Phys. 2011 May 01; 80(1):25-30. Chan LW, Rabban J, Hwang ES, Bevan A, Alvarado M, Ewing C, Esserman L, Fowble B. PMID: 20646871.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    34. Bacteriologic features of surgical site infections following breast surgery. Am J Surg. 2009 Oct; 198(4):529-31. Mukhtar RA, Throckmorton AD, Alvarado MD, Ewing CA, Esserman LJ, Chiu C, Hwang ES. PMID: 19800462.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    35. Emotion work: disclosing cancer. Support Care Cancer. 2010 Feb; 18(2):205-15. Yoo GJ, Aviv C, Levine EG, Ewing C, Au A. PMID: 19434430.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    36. Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer. Breast J. 2009 May-Jun; 15(3):242-6. Lang JE, Liu LC, Lu Y, Jenkins T, Hwang SE, Esserman LJ, Ewing CA, Alvarado M, Morita E, Treseler P, Leong SP. PMID: 19645778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg. 2009 Jan; 249(1):26-32. Garwood ER, Moore D, Ewing C, Hwang ES, Alvarado M, Foster RD, Esserman LJ. PMID: 19106672.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    38. Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer? J Am Coll Surg. 2008 Dec; 207(6):853-8. Liu LC, Lang JE, Jenkins T, Lu Y, Ewing CA, Hwang SE, Sokol S, Alvarado M, Esserman LJ, Morita E, Treseler P, Leong SP. PMID: 19183531.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Surgery for palliation and treatment of advanced breast cancer. Surg Oncol. 2007 Dec; 16(4):249-57. Alvarado M, Ewing CA, Elyassnia D, Foster RD, Shelley Hwang E. PMID: 17976977.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Breast J. 2005 Sep-Oct; 11(5):338-43. Tan YY, Wu CT, Fan YG, Hwang S, Ewing C, Lane K, Esserman L, Lu Y, Treseler P, Morita E, Leong SP. PMID: 16174155.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    41. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Ann Surg Oncol. 2005 Sep; 12(9):705-11. Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP. PMID: 16079953.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    42. Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients. Breast J. 2005 Jul-Aug; 11(4):248-53. Tan YY, Fan YG, Lu Y, Hwang S, Ewing C, Esserman L, Morita E, Treseler P, Leong SP. PMID: 15982390.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol. 2005 Jun; 184(6):1774-81. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, Rugo HS, Hwang ES, Ewing CA, Hylton NM. PMID: 15908529.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    44. Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease. Arch Surg. 2005 Feb; 140(2):196-8; discussion 199-200. Foster RD, Hansen SL, Esserman LJ, Hwang ES, Ewing C, Lane K, Anthony JP. PMID: 15724003.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg. 2004 Dec; 199(6):856-62. Lang JE, Esserman LJ, Ewing CA, Rugo HS, Lane KT, Leong SP, Hwang ES. PMID: 15555967.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. Nonepithelial malignancies mimicking primary carcinoma of the breast. Diagn Cytopathol. 2004 Nov; 31(5):352-7. Ewing CA, Miller MJ, Chhieng D, Lin O. PMID: 15468118.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol. 2002 Apr; 9(3):235-42. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. PMID: 11923129.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    Cheryl's Networks
    Concepts (162)
    Derived automatically from this person's publications.
    _
    Co-Authors (28)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _